Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine-assisted intravenous analgesia after cesarean section for prevention of postpartum depression
ChiCTR1900026379Phase 4Not yet recruiting
- Sponsor
- Women's Hospital, Zhejiang University School of Medicine
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine and butorphanol in postpartum depression (PPD) and postoperative pain (2 arms), sponsored by Women's Hospital, Zhejiang University School of Medicine. Primary endpoints: Edinburgh depression scale and Postoperative pain score. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
dexmedetomidinebutorphanol
03
Conditions
postpartum depression (PPD)postoperative pain
Beyond the preview
Go deeper on ChiCTR1900026379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026379.